Dataset for the proteomic inventory and quantitative analysis of the breast cancer hypoxic secretome associated with osteotropism

T.R. Cox, Erwin Schoof, A. Gartland, J.T. Erler, Rune Linding

    Research output: Contribution to journalJournal articleResearchpeer-review

    264 Downloads (Pure)

    Abstract

    The cancer secretome includes all of the macromolecules secreted by cells into their microenvironment. Cancer cell secretomes are significantly different to that of normal cells reflecting the changes that normal cells have undergone during their transition to malignancy. More importantly, cancer secretomes are known to be active mediators of both local and distant host cells and play an important role in the progression and dissemination of cancer. Here we have quantitatively profiled both the composition of breast cancer secretomes associated with osteotropism, and their modulation under normoxic and hypoxic conditions. We detect and quantify 162 secretome proteins across all conditions which show differential hypoxic induction and association with osteotropism. Mass Spectrometry proteomics data have been deposited to the ProteomeXchange Consortium with the dataset identifier PXD000397 and the complete proteomic, bioinformatic and biological analyses are reported in Cox et al. (2015) [1].
    Original languageEnglish
    JournalData in Brief
    Volume5
    Pages (from-to)621-625
    Number of pages5
    ISSN2352-3409
    DOIs
    Publication statusPublished - 2015

    Bibliographical note

    © 2015 The Authors. Published by Elsevier Inc. This is an open
    access article under the CC BY license

    Keywords

    • Proteomics
    • Breast cancer
    • Bone metastasis
    • Secretome
    • Hypoxia
    • Pre-metastatic Niche
    • Lysyl Oxidase

    Fingerprint Dive into the research topics of 'Dataset for the proteomic inventory and quantitative analysis of the breast cancer hypoxic secretome associated with osteotropism'. Together they form a unique fingerprint.

    Cite this